FDA Commissioner Robert Califf Stressed Need for Long-Term Monitoring of AI
Summary
During the public launch of the nonprofit arm of the Coalition for Health AI (CHAI) on March 5, 2024, FDA Commissioner Califf expressed concern that provider organizations are not equipped to safely implement and test AI tools. He emphasized the need for providers to follow up with patients who have received AI-assisted care and evaluate long-term outcomes. Califf explained that long-term evaluation is necessary to ensure that algorithms retain their effectiveness.
He offered that a network of assurance laboratories that provide local testing of algorithms would help the FDA oversee AI in health care.
Impacted Sectors
Additional Information
© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.